Wilburn Medical USA Announces Distribution of One Millionth CareStart COVID-19 test

Wilburn Medical USA is proud to announce that they have distributed their one millionth CareStart COVID-19 rapid test. Wilburn Medical is a leading distributor of rapid point-of-care antigen tests to combat the growing delta strain outbreak. The CareStart COVID-19 Antigen test uses a shallow nasal swab, reducing discomfort for those undergoing testing, and provides highly accurate results in 10 minutes. This milestone is an important achievement for the company and its dedicated team who are committed to offering affordable, high quality solutions in the detection of SARS-CoV2 infections across the United States.

“There are many antigen tests for the coronavirus and the new variants that are spreading rapidly, we’re seeing a surge in demand for tests out of the new concern,” CEO Emily Wilburn said. “But, we are confident in our ability to provide antigen tests that have the reliability and accuracy such as CareStart.”

“Fortunately, we have strong relationships with the manufacturers. It takes us 24 hours to get pallets of product. We’re finding a number of places that had shut down for testing are now back in business again. We’re here to support those organizations.” said Rick Wilburn, Founder.

Fox News interviews Rick Wilburn: